ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysisTradeArbitrageSearch
By filer · By stock

$REGN:NASDAQ · REGENERON PHARMACEUTICALS INC

Sector: health

Conviction from: NASDAQS&P

Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and commercializes medicines, including the eye drug Eylea and the immunology treatment Dupixent.

2 tracked filer(s) hold this · 0 opened, 0 added, 1 trimmed in 31-MAR-2026

Aggregate 13FScore 48 — mean of 2 scored holder(s). Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Ancora42Holds (flat)105$81,1270.0%
Bridgewater55Trimmed -69%22,724$17,557,4710.1%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

3 disclosed trade(s) by 3 filer(s).

Trade dateWhoTypeAmount
2026-05-15Gilbert Cisneros CA31SELL$1,001 - $15,000PTR
2026-03-27Alan Armstrong senateBUY$1,001 - $15,000PTR
2026-02-12Julia Letlow LA05BUY$1,001 - $15,000PTR

Trump & executive branch trades all Trump/exec trades →

7 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$100,001 - $250,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR

Citrini Research coverage report library →

ReportDateStance
#102 — GLP-1s: The Second Serving - Revisiting our GLP-1 Basket2025-07-24WATCH

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.